RPG Life Sciences Limited — Board Meeting, 24-01-2025: Outcome of Board Meeting

The Board of Directors has approved the unaudited financial results for the quarter ended December 31, 2024, reflecting a revenue from operations of ₹172.71 crore and a net profit of ₹34.93 crore. The board also approved revisions to the Code of Fair Disclosure and the Policy on Related Party Transactions. Notably, exceptional items include transfer charges of ₹27.30 crore attributed to an order from the Maharashtra Industrial Development Corporation. Additionally, a recent fire incident at the company’s manufacturing plant has affected assets, with damage assessment currently underway, but all other operations remain unaffected.